Lawyer profile
Carolin Kemmner
Clifford Chance
- Firm
- Clifford Chance
- Practice
- Corporate/Healthcare, Healthcare, Healthcare/Compliance
- Office
- Dusseldorf, Düsseldorf
- Active in the record
- 2020 to 2024
Deal experience
Deal types
Sectors
Deals
6 announced deals in the record Clifford Chance advises Heilpflanzenwohl AG on its acquisition of two OTC products from Haleon 14 Nov 2024
Clifford Chance advises CBC Group and Mubadala on the acquisition of UCB’s mature business (neurology and allergy) in China 28 Sept 2024
Clifford Chance advises Keymed Biosciences Inc. on out-licensing transaction with Belenos Biosciences 14 Aug 2024
Clifford Chance advises Paragon Partners on its investment in Primed Group 9 Nov 2023
Clifford Chance advises investors’ consortium comprising OMERS, Goldman Sachs and AXA on acquisition of leading laboratory services provider amedes 3 Aug 2021
Clifford Chance advises Permira on the acquisition of Neuraxpharm 23 Sept 2020
Deal alerts PRO
Get an email when Carolin Kemmner is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile